Perceive Pharma

Private

South San Francisco, CaliforniaHealthcare & Life Scienceshttp://perceivepharma.com/

Last Round

Series A

Feb 18, 2025

Est. Valuation

$169M

Total Funding Raised

$15M

Company Overview

Perceive Pharma is a drug discovery company that is advancing novel small molecule neuroprotective therapeutics, with lead pipeline programs in glaucoma and other ophthalmic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neuroprotective therapeuticssmall molecule drugsglaucoma treatmentophthalmologybiopharmaretinal neuroprotectionIOP-independent therapydrug discoverydrug developmentclinical stage pharmafirst-in-class drugpharma licensinggenomic screeninglife science incubator

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Perceive Pharma Comps

Public and private peers based on sector, stage, and business model.

Perceive Pharma comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Perceive Pharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Feb 18, 2025
Series A	Aug 1, 2018

View all Funding Rounds

Perceive Pharma Investors

Notable investors and investment history

Perceive Pharma investors
Investor	Rounds
Deerfield Management	Series A
GV	Series A
Braidwell	Series A
Catalio Capital Management	Series A
Johnson & Johnson Innovation - JJDC	Series A
Foundation Fighting Blindness	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 18, 2025
$15M round led by Deerfield Management
Aug 1, 2018
Deerfield Management led the Series A round.

View all signals

Perceive Pharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Perceive Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Perceive Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California

Year Founded2025

Last FundingFeb 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.